Focus on Equities that offer Growth,
Value and Strong Potential Return
Wednesday, April 23, 2014

Sarepta Therapeutics, Inc.

In-Depth Research Report Available for SRPT

Download Free Report Now

Company Profile SRPT

Sarepta Therapeutics shares declined 8.17 percent to close at $18.77 a share Monday. The stock traded between $17.76 and $19.60 on volume of 4.23 million shares traded. Analysts at Citigroup have recently downgraded the company’s rating to “sell” from “neutral”. Shares of Sarepta Therapeutics have fallen approximately 35.0 percent over the past year. Going forward ... (see research report)

News & Events SRPT